SimeonIsraelTaylorMD

PubMed

• Sodium-Glucose Cotransporter 2 Inhibitors: A Case Study in Translational Research.
  Beitelshees, A. L.,Leslie, B. R.,Taylor, S. I.> ;Diabetes. 2019 May 22
• Insulin Access and Affordability Working Group: Conclusions and Recommendations
  Simeon Taylor, MD> ;Diabetes Care. 2018 May 10
• Cardiovascular outcome trials of diabetes drugs: lessons learned.
  Taylor, S. I.,Leslie, B. R.> ;J. Clin. Invest.. 2018 Feb 13
• When translation meets metabolism: multiple links to diabetes.
  Shi, Y., Taylor, S.I., Tan, S., Sonenberg, N.> ;Endocr Rev. 2003 Feb
• Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy.
  Petersen, K.F., Oral, E.A., Dufour, S., Befroy, D., Ariyan, C., Yu, C., Cline, G.W., DePaoli, A.M., Taylor, S.I., Gorden, P., Shulman, G.I.> ;J Clin Invest. 2002 May
• AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34.
  Agarwal, A.K., Arioglu, E., De Almeida, S., Akkoc, N., Taylor, S.I., Bowcock, A.M., Barnes, R.I., Garg, A.> ;Nat Genet. 2002 May
• sgk: an essential convergence point for peptide and steroid hormone regulation of ENaC-mediated Na+ transport.
  Faletti, C.J., Perrotti, N., Taylor, S.I., Blazer-Yost, B.L.> ;Am J Physiol Cell Physiol. 2002 Mar
• Clinical course of the syndrome of autoantibodies to the insulin receptor (type B insulin resistance): a 28-year perspective.
  Arioglu, E., Andewelt, A., Diabo, C., Bell, M., Taylor, S.I., Gorden, P.> ;Medicine (Baltimore). 2002 Mar
• Leptin-replacement therapy for lipodystrophy.
  Oral, E.A., Simha, V., Ruiz, E., Andewelt, A., Premkumar, A., Snell, P., Wagner, A.J., DePaoli, A.M., Reitman, M.L., Taylor, S.I., Gorden, P., Garg, A.> ;N Engl J Med. 2002 Feb 21
• Familial lipodystrophy associated with neurodegeneration and congenital cataracts.
  Berger, J.R., Oral, E.A., Taylor, S.I.> ;Neurology. 2002 Jan 8
• Join now to see all